1. Home
  2. FNWB vs VIGL Comparison

FNWB vs VIGL Comparison

Compare FNWB & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNWB
  • VIGL
  • Stock Information
  • Founded
  • FNWB 1923
  • VIGL 2020
  • Country
  • FNWB United States
  • VIGL United States
  • Employees
  • FNWB N/A
  • VIGL N/A
  • Industry
  • FNWB Banks
  • VIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • FNWB Finance
  • VIGL Health Care
  • Exchange
  • FNWB Nasdaq
  • VIGL Nasdaq
  • Market Cap
  • FNWB 89.9M
  • VIGL 89.3M
  • IPO Year
  • FNWB 2015
  • VIGL 2022
  • Fundamental
  • Price
  • FNWB $10.86
  • VIGL $2.66
  • Analyst Decision
  • FNWB Hold
  • VIGL Strong Buy
  • Analyst Count
  • FNWB 1
  • VIGL 5
  • Target Price
  • FNWB $12.00
  • VIGL $21.00
  • AVG Volume (30 Days)
  • FNWB 15.9K
  • VIGL 2.6M
  • Earning Date
  • FNWB 01-29-2025
  • VIGL 03-25-2025
  • Dividend Yield
  • FNWB 2.59%
  • VIGL N/A
  • EPS Growth
  • FNWB N/A
  • VIGL N/A
  • EPS
  • FNWB N/A
  • VIGL N/A
  • Revenue
  • FNWB $50,900,000.00
  • VIGL N/A
  • Revenue This Year
  • FNWB N/A
  • VIGL N/A
  • Revenue Next Year
  • FNWB $11.60
  • VIGL N/A
  • P/E Ratio
  • FNWB N/A
  • VIGL N/A
  • Revenue Growth
  • FNWB N/A
  • VIGL N/A
  • 52 Week Low
  • FNWB $8.91
  • VIGL $1.49
  • 52 Week High
  • FNWB $16.00
  • VIGL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • FNWB 60.31
  • VIGL 66.89
  • Support Level
  • FNWB $10.80
  • VIGL $2.53
  • Resistance Level
  • FNWB $11.10
  • VIGL $2.88
  • Average True Range (ATR)
  • FNWB 0.22
  • VIGL 0.30
  • MACD
  • FNWB 0.03
  • VIGL 0.06
  • Stochastic Oscillator
  • FNWB 75.00
  • VIGL 70.98

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.

Share on Social Networks: